When evaluating margin status to consider APBI for early stage invasive breast cancer, given the specification for at least 2 mm margins, do you look at the DCIS margin or only the invasive margin?
Additionally, when evaluating margin status for APBI IMRT 30 Gy in 5 fractions which specifies at least 5 mm margins, do you look at the DCIS margin or only the invasive margin?
Answer from: Radiation Oncologist at Academic Institution
I take a slightly different approach. Current guidelines for breast conserving surgery allow for no tumor on ink for invasive cancers, even those with DCIS associated. While ASTRO guidelines recommend 2 mm for APBI (Correa et al., PMID 27866865), other guidelines such as the ABS do not for invasive ...
Answer from: Radiation Oncologist at Academic Institution
I would always consider both. DCIS recurrence rates after radiation (NSABP for example) have always been higher than for invasive cancer. Microinvasive cancer will often have recurrence rates similar to DCIS.
Silverstein published his results in his articles and book based on close pathological eva...
Answer from: Radiation Oncologist at Community Practice
Great question! I agree that both Invasive and DCIS margins are important and must be considered. Regarding the more recently published Livi 5 fractioned APBI, personal and institutional eligibility criteria are preferential.However, anytime I adopt a new protocol for my clinic, I think it is invalu...
Comments
Radiation Oncologist at Kaiser Permanente Many of these patients are over 65 and may be cand...
Radiation Oncologist at Cleveland Clinic I would agree with you. Also, I have more patients...
Radiation Oncologist at Northeast Alabama Regional Medical Center Dr. @Thomas D. Wynne has a good point. Also this w...
Radiation Oncologist at Aurora Medical Center-Kenosha In the updated 2023 APBI guidelines, there appears...
Radiation Oncologist at Cleveland Clinic I tend to be comfortable with PBI with otherwise l...